My Companies
Notification
Account
Lord’s Mark received India’s first and only manufacturing licence for an In Vitro Diagnostic Software (SaMD) for its Biomescan gut-microbiome analytics platform under the Medical Devices Rules, 2017. The company plans to expand through a nationwide network of health and wellness centres with hospitals and healthcare professionals.
Lords Mark Industries To Consider ₹100 Crore Convertible Promoter Loan
Lords Mark Industries Achieves 25% MPS After Second Promoter Stake Sale
Lords Mark Industries Promoter Sells 2.43 Percent Stake Via Open Market
Lords Mark Industries Enters ARKALL Collaboration Targeting US$100 Million Export Revenue
Lord's Mark Unveils ₹1,550 Crore FY27 Guidance And Healthcare Expansion